Fox Chase Cancer Center’s Department of Clinical Genetics Expands Reach With Genetic Counseling and High-Risk Clinical Services at Chestnut Hill Hospital

Corinne
Corinne Zrada, MS, LCGC, a licensed and board-certified genetic counselor, will be part of a new team at Temple Health – Chestnut Hill Hospital offering genetic counseling and clinical services for those considered at high risk for breast cancer.

PHILADELPHIA (December 3, 2024) The Department of Clinical Genetics at Fox Chase Cancer Center is pleased to announce that genetic counseling, a service that helps individuals and families understand inherited health risks, and clinical services for those considered at high risk for breast cancer are now offered at Temple Health - Chestnut Hill Hospital.  

“We have had genetic counseling available for patients at Fox Chase for over 20 years and we look forward to expanding our services to the Chestnut Hill community,” said Corinne Zrada, MS, LCGC, a licensed and board-certified genetic counselor. “Genetic counseling is essential for individuals with a personal or family history of cancer to assess their risks and make informed decisions about their health.”

The expansion of genetic counseling services to Chestnut Hill Hospital, which is located at 8835 Germantown Avenue in Philadelphia, allows individuals with a personal or family history of cancer to assess their risk. During genetic counseling appointments, patients will meet with a licensed genetic counselor to review their medical and family history. These weekly clinics will be held every Wednesday and Thursday.

In addition, Chestnut Hill will offer genetic testing and explanations of the results in follow-up appointments. Genetic testing analyzes DNA from a blood or saliva sample to detect changes or mutations that may increase a person’s risk for cancer. Understanding genetic risks allows patients to take steps to lower their chances of developing cancer or detecting it early.  

The services at Chestnut Hill will be provided by an expert team, including Zrada; Dylane Wineland, MS, LCGC, a licensed genetic counselor; and Devora Schapiro, MSPAS, PA-C, a licensed physician assistant who will be offering clinical services for those considered to be at high risk for breast cancer.  

This expansion aligns with the mission of the Department of Clinical Genetics, which is to provide genetic counseling and high-risk clinical services to individuals at an increased risk for cancer, furthering the goal of cancer prevention.

Appointments can be made by calling 877-627-9684. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text